Dutch Delegation Promises ‘Seamless’ Transition To EMA’s New Home

Dutch officials took part in the December meeting of the EMA management board and presented details of their plans for the agency’s relocation to Amsterdam. The board also adopted the 2018 work program and budget, which allow for a 6.8% rise in fee-related revenue next year, and said phase 2 of the Brexit business continuity plan would begin in January.

Removals — The Dutch are promising the EMA a "seamless" move to Amsterdam

The European Medicines Agency and the Dutch authorities have agreed a joint governance structure to guide and oversee the agency’s move from London as a result of Brexit, with the aim of effecting a smooth relocation of the agency’s activities to its new home in Amsterdam by March 30, 2019.

As part of the relocation process, a Dutch delegation traveled to London to present the EMA’s management board’s December meeting...